Curaleaf is a cannabis company that grows, processes, and sells cannabis products for medical and recreational use. It offers items such as tinctures, flowers, and edibles, and uses encapsulation technology to improve product absorption and effectiveness. Customers can buy at dispensaries or online, and the company also provides medical consultations and guidance services. Differentiators include its vertically integrated model (cultivation, processing, and retail) and its social responsibility efforts, such as the B NOBLE program that supports individuals with cannabis-related non-violent charges. The company’s goal is to provide reliable cannabis products and related services to a wide range of customers while advancing responsible access and advocacy through programs like B NOBLE.
Work here?Claim your company
Industries
Company Size
1,001-5,000
Company Stage
IPO
Headquarters
Stamford, CT
Founded
2010
See people who can refer or advise you
Help us improve and share your feedback! Did you find this helpful?
Total Funding
$2.5B
Above
Industry Average
Funded Over
12 Rounds
Curaleaf reported record third-quarter 2026 net revenue of $353 million, up 11% from a year earlier. Domestic revenue grew 8% and international revenue rose 28% to $59 million. Adjusted EBITDA was $78 million, a 22% margin, while adjusted gross margin was 49%. The company posted a net loss of $37.4 million from continuing operations and ended the quarter with $105 million in cash. Curaleaf opened two Florida dispensaries in the quarter, bringing its operated and managed total to 188. It also launched an offer to buy Aurora Cannabis, which later announced an alternative merger with Organigram. Curaleaf is weighing its options. It still targets about $150 million in operating cash flow for the year.
Curaleaf has acquired an equity stake and certain operating rights in Boone Town Provisions, a dispensary in Boonton, New Jersey. The deal brings the cannabis company to four dispensaries in the state and 191 nationwide. Curaleaf expects the store to add to earnings immediately. Chairman and chief executive officer Boris Jordan called it "one of the top-performing dispensaries in New Jersey" and said the interest was bought at an attractive valuation. The company did not disclose the price. The 6,400-square-foot store opened in July 2024 on a busy stretch of Myrtle Avenue with few dispensaries nearby. Curaleaf's other New Jersey stores are in Bellmawr, Bordentown, and Edgewater Park.
Curaleaf Holdings has pushed back after the Alberta Securities Commission (ASC) ruled on Aurora Cannabis' at-the-market (ATM) share program, saying the decision does not change the debate over its takeover bid. Chief executive officer Boris Jordan said Aurora shareholders still face unanswered questions, including why Aurora issued shares under the ATM below the original offer price after Curaleaf signalled a bid. Curaleaf says its enhanced offer of about $5.00 a share is an 86% premium to Aurora's unaffected average price of about $2.75. It says Aurora sold shares as low as $2.56 under the ATM, and that it remains excluded from customary diligence. Curaleaf says a combined company would operate in 17 countries, with more than $1.5 billion in last-twelve-month revenue and at least $40 million in expected annual cost synergies.
Curaleaf Holdings has issued a letter urging Aurora Cannabis shareholders to accept its takeover offer, which represents a 45% premium over Aurora's 30-day volume weighted average price. The acquisition would create a combined company operating across 17 countries with US$1.5 billion in last twelve-month revenue and nearly US$350 million of adjusted EBITDA. Curaleaf Chairman and CEO Boris Jordan framed the decision starkly, describing Aurora as "a shrinking business that is burning cash and getting less profitable by the day." The company expects at least US$40 million in annual cost synergies from the combination. Aurora has refused to engage with Curaleaf's proposal. Jordan announced a live shareholder Q&A session scheduled for 17 September to discuss the offer directly with Aurora investors.
Curaleaf Holdings has opened a new cannabis dispensary in downtown Boston at 21 Milk St., near Downtown Crossing. The location opened on 4 September, offering patients expanded retail space and a broader selection of products. The dispensary will stock Curaleaf's portfolio of cannabis brands, including Dark Heart, Select, FIND, Anthem and Grassroots. Knowledgeable staff will assist customers in selecting products suited to their needs. A grand opening celebration is scheduled for 8 September, featuring in-store promotions, a Meet the Grower event, and brand activations. The store operates from 09:00 to 20:00 Monday through Saturday, and 09:00 to 18:00 on Sunday. The opening follows the closure of Curaleaf's former Provincetown dispensary.
Find jobs on Simplify and start your career today
Don't see your dream role? Check out thousands of other roles on Simplify.Browse all jobs
Industries
Company Size
1,001-5,000
Company Stage
IPO
Headquarters
Stamford, CT
Founded
2010
Find jobs on Simplify and start your career today
Don't see your dream role? Check out thousands of other roles on Simplify.Browse all jobs